RGD DISEASE ONTOLOGY - ANNOTATIONS
RGD uses the Human Disease Ontology (DO, https://disease-ontology.org/) for disease curation across species. RGD automatically downloads each new release of the ontology on a monthly basis. Some additional terms which are required for RGD's curation purposes but are not currently covered in the official version of DO have been added. As corresponding terms are added to DO, these custom terms are retired and the DO terms substituted in existing annotations and subsequently used for curation.
Term: Carcinogenesis
Accession: DOID:9007702
browse the term
Definition: The origin, production or development of cancer through genotypic and phenotypic changes which upset the normal balance between cell proliferation and cell death. Carcinogenesis generally requires a constellation of steps, which may occur quickly or over a period of many years.
Synonyms: exact_synonym: Carcinogeneses; Oncogeneses; Oncogenesis; Tumorigeneses; Tumorigenesis
primary_id: MESH:D063646
G
Abl1
ABL proto-oncogene 1, non-receptor tyrosine kinase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23968727
NCBI chr 3:14,979,853...15,083,065
Ensembl chr 3:14,979,853...15,083,065
G
Adprh
ADP-ribosylarginine hydrolase
ISO
RGD
PMID:21697277
RGD:13838723
NCBI chr11:62,299,831...62,306,170
Ensembl chr11:62,299,793...62,306,931
G
Akr1a1
aldo-keto reductase family 1 member A1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:32805337
NCBI chr 5:130,092,945...130,130,277
Ensembl chr 5:130,092,732...130,113,674
G
Akt1
AKT serine/threonine kinase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:32045588
NCBI chr 6:131,713,716...131,735,319
Ensembl chr 6:131,713,720...131,733,921
G
Braf
B-Raf proto-oncogene, serine/threonine kinase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:24717435
NCBI chr 4:68,375,484...68,510,652
Ensembl chr 4:68,384,649...68,510,463
G
Cav1
caveolin 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:29247004
NCBI chr 4:45,640,624...45,673,708
Ensembl chr 4:45,634,918...45,673,705
G
Cdkn2a
cyclin-dependent kinase inhibitor 2A
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21526190
NCBI chr 5:103,984,949...103,992,143
Ensembl chr 5:103,984,949...104,003,149
G
Cux1
cut-like homeobox 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:24316979
NCBI chr12:20,107,062...20,425,868
Ensembl chr12:20,107,311...20,425,866
G
Dnmt1
DNA methyltransferase 1
disease_progression
IDA
RGD
PMID:21163286
RGD:9588222
NCBI chr 8:19,440,611...19,486,659
Ensembl chr 8:19,440,611...19,486,659
G
Dnmt3a
DNA methyltransferase 3 alpha
disease_progression
IDA
RGD
PMID:21163286
RGD:9588222
NCBI chr 6:26,791,517...26,902,161
Ensembl chr 6:26,822,609...26,896,687
G
Epas1
endothelial PAS domain protein 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:26735578
NCBI chr 6:7,790,236...7,871,717
Ensembl chr 6:7,790,647...7,871,228
G
Erbb2
erb-b2 receptor tyrosine kinase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25221644
NCBI chr10:83,411,197...83,435,078
Ensembl chr10:83,411,313...83,435,078
G
Gata3
GATA binding protein 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:35115686
NCBI chr17:68,643,760...68,666,000
Ensembl chr17:68,643,873...68,665,391
G
H19
H19 imprinted maternally expressed transcript
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:32739445
NCBI chr 1:197,730,698...197,733,374
Ensembl chr 1:197,730,698...197,733,134
G
Isg15
ISG15 ubiquitin-like modifier
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:35506701
NCBI chr 5:166,784,148...166,785,435
Ensembl chr 5:166,784,148...166,785,435
G
Kras
KRAS proto-oncogene, GTPase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:26595770 PMID:29247004
NCBI chr 4:178,185,418...178,218,484
G
Map3k8
mitogen-activated protein kinase kinase kinase 8
ISO
RGD
PMID:15287022 PMID:23533274
RGD:151356924 , RGD:151356978
NCBI chr17:53,382,908...53,403,216
Ensembl chr17:53,383,131...53,403,216
G
Met
MET proto-oncogene, receptor tyrosine kinase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:32045588
NCBI chr 4:45,790,456...45,898,139
Ensembl chr 4:45,790,791...45,897,876
G
Mir143
microRNA 143
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:28736328
NCBI chr18:55,101,006...55,101,110
Ensembl chr18:55,101,006...55,101,110
G
Nfe2l2
NFE2 like bZIP transcription factor 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:29228771
NCBI chr 3:60,594,239...60,621,712
Ensembl chr 3:60,594,242...60,621,737
G
Pafah1b1
platelet-activating factor acetylhydrolase 1b, regulatory subunit 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:24487275
NCBI chr10:59,533,042...59,591,808
Ensembl chr10:59,534,117...59,591,808
G
Pou5f1
POU class 5 homeobox 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:35506701
NCBI chr20:3,223,128...3,227,891
Ensembl chr20:3,223,129...3,227,891
G
Sparc
secreted protein acidic and cysteine rich
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:26783756
NCBI chr10:39,516,394...39,538,252
Ensembl chr10:39,516,406...39,538,396
G
Tnfsf8
TNF superfamily member 8
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:11552987
NCBI chr 5:77,250,942...77,277,364
Ensembl chr 5:77,251,373...77,277,421
G
Aicda
activation-induced cytidine deaminase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21570118
NCBI chr 4:155,774,132...155,783,972
Ensembl chr 4:155,774,132...155,783,972
G
Bcr
BCR activator of RhoGEF and GTPase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21570118
NCBI chr20:13,469,325...13,596,942
Ensembl chr20:13,471,668...13,597,016
G
Esr2
estrogen receptor 2
ISO
RGD
PMID:12740446
RGD:734951
NCBI chr 6:94,858,438...94,909,630
Ensembl chr 6:94,809,547...94,908,919
G
Hmox1
heme oxygenase 1
ISO
RGD
PMID:22139798
RGD:10755566
NCBI chr19:13,466,287...13,474,082
Ensembl chr19:13,467,244...13,474,079
G
Mir150
microRNA 150
ISO
miRNA:decreased expression:leukocytes
RGD
PMID:21501493
RGD:13782140
NCBI chr 1:95,605,024...95,605,108
Ensembl chr 1:95,605,024...95,605,108
G
Tcn2
transcobalamin 2
ISO
protein:increased expression::
RGD
PMID:1059479
RGD:11060122
NCBI chr14:78,813,343...78,828,549
Ensembl chr14:78,813,343...78,828,489
G
Actg1
actin, gamma 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25401301
NCBI chr10:105,619,738...105,622,587
Ensembl chr10:105,619,737...105,624,232 Ensembl chr 3:105,619,737...105,624,232
G
Akr1c1
aldo-keto reductase family 1, member C1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19696165
NCBI chr17:65,810,474...65,837,385
Ensembl chr17:65,810,475...65,837,326
G
Akr1c2
aldo-keto reductase family 1, member C2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19696165
NCBI chr17:65,759,778...65,808,013
Ensembl chr17:65,759,788...65,775,764
G
Akr1c3
aldo-keto reductase family 1, member C3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19696165
NCBI chr17:66,110,970...66,127,867
Ensembl chr17:66,110,963...66,127,873
G
Aldh1a1
aldehyde dehydrogenase 1 family, member A1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:26783756 PMID:29626521
NCBI chr 1:218,000,470...218,152,962
Ensembl chr 1:218,042,127...218,152,961
G
Alk
ALK receptor tyrosine kinase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22286764 PMID:23104988
NCBI chr 6:22,879,653...23,599,636
Ensembl chr 6:22,880,625...23,598,034
G
Apc
APC regulator of WNT signaling pathway
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19092804 PMID:21967605
NCBI chr18:25,828,558...25,925,511
Ensembl chr18:25,864,222...25,922,696
G
Arl6ip5
ADP-ribosylation factor like GTPase 6 interacting protein 5
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:29545876
NCBI chr 4:129,810,650...129,838,628
Ensembl chr 4:129,810,645...129,838,608
G
Atf3
activating transcription factor 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:34364923
NCBI chr13:102,751,278...102,800,520
Ensembl chr13:102,751,321...102,764,631
G
Bcl2
BCL2, apoptosis regulator
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:2543982 PMID:2848196 PMID:22666341
NCBI chr13:22,689,783...22,853,920
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
G
Brca1
BRCA1, DNA repair associated
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22048643
NCBI chr10:86,417,441...86,477,762
Ensembl chr10:86,418,000...86,477,304
G
Cat
catalase
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:20516118 PMID:21742780 PMID:23518002 PMID:25448439 PMID:27323401 PMID:28881718 More...
NCBI chr 3:89,842,393...89,874,577
Ensembl chr 3:89,842,399...89,874,478
G
Ccnd1
cyclin D1
ISO
CTD Direct Evidence: marker/mechanism|therapeutic
CTD
PMID:21726611 PMID:24362009
NCBI chr 1:200,089,002...200,098,524
Ensembl chr 1:200,089,002...200,098,602
G
Cd34
CD34 molecule
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22011395
NCBI chr13:106,480,313...106,500,844
Ensembl chr13:106,480,043...106,499,832
G
Cdh1
cadherin 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:24014025
NCBI chr19:34,492,371...34,561,775
Ensembl chr19:34,492,371...34,561,775
G
Cdkl2
cyclin dependent kinase like 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25333262
NCBI chr14:16,027,381...16,063,257
Ensembl chr14:16,028,363...16,063,252
G
Chrna9
cholinergic receptor nicotinic alpha 9 subunit
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:30259641
NCBI chr14:42,235,218...42,241,939
Ensembl chr14:42,235,226...42,242,192
G
Cldn1
claudin 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:24014025
NCBI chr11:74,421,569...74,436,728
Ensembl chr11:74,421,569...74,436,724
G
Ctbp2
C-terminal binding protein 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28414304
NCBI chr 1:187,782,064...187,918,115
Ensembl chr 1:187,782,682...187,920,222
G
Ctnnb1
catenin beta 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:29626521
NCBI chr 8:120,640,008...120,667,110
Ensembl chr 8:120,639,995...120,667,111
G
Ctnnd2
catenin delta 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23917401
NCBI chr 2:81,168,525...82,016,495
Ensembl chr 2:81,167,117...82,015,764
G
Cxcr4
C-X-C motif chemokine receptor 4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23743303
NCBI chr13:40,077,976...40,081,883
Ensembl chr13:40,077,976...40,081,883
G
Cyp2a1
cytochrome P450, family 2, subfamily a, polypeptide 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:26084420
NCBI chr 1:82,231,611...82,244,887
Ensembl chr 1:82,231,611...82,244,887
G
E4f1
E4F transcription factor 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:30506647
NCBI chr10:13,471,478...13,495,018
Ensembl chr10:13,474,456...13,485,974
G
Ebf1
EBF transcription factor 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:24362818
NCBI chr10:29,095,858...29,489,142
Ensembl chr10:29,099,933...29,487,665
G
Edn1
endothelin 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25194819
NCBI chr17:22,454,924...22,460,812
Ensembl chr17:22,454,420...22,460,885
G
Egf
epidermal growth factor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12687016 PMID:18245498 PMID:18995957
NCBI chr 2:218,219,408...218,302,359
Ensembl chr 2:218,219,415...218,302,064
G
Ehmt2
euchromatic histone lysine methyltransferase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:29391238
NCBI chr20:3,919,623...3,936,751
Ensembl chr20:3,919,624...3,941,547
G
Eif3i
eukaryotic translation initiation factor 3, subunit I
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:11830523 PMID:24056964
NCBI chr 5:141,935,135...141,942,589
Ensembl chr 5:141,935,044...141,942,676
G
Eno2
enolase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22613180
NCBI chr 4:157,572,085...157,580,971
Ensembl chr 4:157,572,088...157,580,980
G
Epas1
endothelial PAS domain protein 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23333640 PMID:26735578 PMID:30090327
NCBI chr 6:7,790,236...7,871,717
Ensembl chr 6:7,790,647...7,871,228
G
Errfi1
ERBB receptor feedback inhibitor 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28688920
NCBI chr 5:161,323,981...161,337,289
Ensembl chr 5:161,323,998...161,337,282
G
Esr1
estrogen receptor 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:24014025 PMID:27366082
NCBI chr 1:41,106,335...41,499,104
Ensembl chr 1:41,210,475...41,495,002
G
Esr2
estrogen receptor 2
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:22398780
NCBI chr 6:94,858,438...94,909,630
Ensembl chr 6:94,809,547...94,908,919
G
Ezh2
enhancer of zeste 2 polycomb repressive complex 2 subunit
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:29391238
NCBI chr 4:76,624,399...76,687,362
Ensembl chr 4:76,624,399...76,687,362
G
Fn1
fibronectin 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:24014025
NCBI chr 9:73,196,044...73,264,695
Ensembl chr 9:73,196,044...73,264,678
G
Fos
Fos proto-oncogene, AP-1 transcription factor subunit
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:8777434
NCBI chr 6:105,121,170...105,124,036
Ensembl chr 6:105,121,170...105,124,036
G
Foxa1
forkhead box A1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:32717239
NCBI chr 6:75,099,907...75,136,534
Ensembl chr 6:75,103,503...75,136,188
G
Gclc
glutamate-cysteine ligase, catalytic subunit
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:30940545
NCBI chr 8:78,629,899...78,668,547
Ensembl chr 8:78,630,127...78,668,544
G
Git1
GIT ArfGAP 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28100775
NCBI chr10:62,342,082...62,356,379
Ensembl chr10:62,342,299...62,356,373
G
Gsk3b
glycogen synthase kinase 3 beta
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:29626521
NCBI chr11:62,498,997...62,648,665
Ensembl chr11:62,504,316...62,648,646
G
H19
H19 imprinted maternally expressed transcript
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:32739445
NCBI chr 1:197,730,698...197,733,374
Ensembl chr 1:197,730,698...197,733,134
G
Hif1a
hypoxia inducible factor 1 subunit alpha
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:29501572
NCBI chr 6:92,624,059...92,669,262
Ensembl chr 6:92,624,390...92,669,261
G
Hmgn1
high mobility group nucleosome binding domain 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:24747640
NCBI chr11:35,422,328...35,428,247
Ensembl chr11:35,422,328...35,428,254
G
Hras
HRas proto-oncogene, GTPase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12115494 PMID:18245498 PMID:18829283 PMID:22048643 PMID:23877152
NCBI chr 1:196,290,127...196,299,823
Ensembl chr 1:196,296,263...196,300,615
G
Igbp1
immunoglobulin binding protein 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21339737
NCBI chr X:65,582,832...65,605,078
Ensembl chr X:65,582,821...65,606,049
G
Igf1r
insulin-like growth factor 1 receptor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23748240
NCBI chr 1:121,549,831...121,838,548
Ensembl chr 1:121,550,743...121,831,777
G
Igf2bp1
insulin-like growth factor 2 mRNA binding protein 1
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:34974052
NCBI chr10:80,908,300...80,951,097
Ensembl chr10:80,908,076...80,951,129
G
Il6
interleukin 6
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23593346 PMID:26101800
NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178
G
Il7r
interleukin 7 receptor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21892159
NCBI chr 2:58,452,393...58,477,757
Ensembl chr 2:58,454,217...58,477,757
G
Irs1
insulin receptor substrate 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23748240
NCBI chr 9:83,552,964...83,605,797
Ensembl chr 9:83,548,944...83,606,122
G
Jak2
Janus kinase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:35568132
NCBI chr 1:226,995,334...227,054,381
Ensembl chr 1:226,995,334...227,054,189
G
Jun
Jun proto-oncogene, AP-1 transcription factor subunit
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:8777434 PMID:21726611
NCBI chr 5:109,894,175...109,897,268
Ensembl chr 5:109,893,145...109,897,656
G
Kcnd2
potassium voltage-gated channel subfamily D member 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:34418280
NCBI chr 4:49,775,812...50,277,746
Ensembl chr 4:49,776,246...50,277,728
G
Kcnh2
potassium voltage-gated channel subfamily H member 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:24830940
NCBI chr 4:10,826,834...10,859,009
Ensembl chr 4:10,826,928...10,859,008
G
Kras
KRAS proto-oncogene, GTPase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27510461
NCBI chr 4:178,185,418...178,218,484
G
Krt14
keratin 14
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22011395
NCBI chr10:85,137,786...85,142,054
Ensembl chr10:85,066,802...85,171,799
G
Krt15
keratin 15
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22011395
NCBI chr10:85,066,797...85,070,614
Ensembl chr10:85,066,802...85,171,799
G
Krt19
keratin 19
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22011395
NCBI chr10:85,075,835...85,080,552
Ensembl chr10:85,066,802...85,171,799
G
Krt5
keratin 5
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22011395
NCBI chr 7:132,846,132...132,851,861
Ensembl chr 7:132,846,136...132,851,850
G
Lgals3
galectin 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16322222
NCBI chr15:20,620,083...20,632,019
Ensembl chr15:20,607,692...20,632,025
G
Lin28a
lin-28 homolog A
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19483683
NCBI chr 5:146,227,119...146,244,122
Ensembl chr 5:146,227,119...146,244,122
G
Lin28b
lin-28 homolog B
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19483683
NCBI chr20:48,865,329...48,964,769
Ensembl chr20:48,869,485...48,955,077
G
Loxl2
lysyl oxidase-like 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:24014025
NCBI chr15:44,683,449...44,773,067
Ensembl chr15:44,683,880...44,773,067
G
Mapk8
mitogen-activated protein kinase 8
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21726611
NCBI chr16:8,638,897...8,721,960
Ensembl chr16:8,638,924...8,721,981
G
Mdm2
MDM2 proto-oncogene
susceptibility
ISO
CTD Direct Evidence: marker/mechanism
CTD OMIM
PMID:15550242
NCBI chr 7:53,290,660...53,315,205
Ensembl chr 7:53,290,664...53,314,915
G
Meg3
maternally expressed 3
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:34520792
NCBI chr 6:128,491,808...128,524,010
G
Mir106a
microRNA 106a
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20889678
NCBI chr X:132,422,584...132,422,661
Ensembl chr X:132,422,584...132,422,661
G
Mir143
microRNA 143
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:26721309
NCBI chr18:55,101,006...55,101,110
Ensembl chr18:55,101,006...55,101,110
G
Mir146a
microRNA 146a
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22048643
NCBI chr10:27,848,516...27,848,610
Ensembl chr10:27,848,516...27,848,610
G
Mir155
microRNA 155
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28688901
NCBI chr11:23,774,654...23,774,718
Ensembl chr11:23,774,654...23,774,718
G
Mir15b
microRNA 15b
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22048643
NCBI chr 2:153,245,200...153,245,297
Ensembl chr 2:153,245,200...153,245,297
G
Mir185
microRNA 185
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22048643
NCBI chr11:82,664,716...82,664,795
Ensembl chr11:82,664,716...82,664,795
G
Mir190
microRNA 190
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21750348
NCBI chr 8:67,850,987...67,851,071
Ensembl chr 8:67,850,987...67,851,071
G
Mir191
microRNA 191
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22048643 PMID:29277653
NCBI chr 8:109,264,098...109,264,188
G
Mir200b
microRNA 200b
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21292642
NCBI chr 5:166,649,272...166,649,366
Ensembl chr 5:166,649,272...166,649,366
G
Mir205
microRNA 205
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22048643
NCBI chr13:105,035,878...105,035,985
Ensembl chr13:105,035,878...105,035,985
G
Mir21
microRNA 21
ISO
CTD Direct Evidence: marker/mechanism|therapeutic
CTD
PMID:26101800 PMID:27323401 PMID:27344173 PMID:28881718 PMID:29501572
NCBI chr10:71,405,257...71,405,348
Ensembl chr10:71,405,257...71,405,348
G
Mir221
microRNA 221
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22048643
NCBI chr X:3,429,465...3,429,573
Ensembl chr X:3,429,465...3,429,573
G
Mir25
microRNA 25
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22048643
NCBI chr12:17,042,932...17,043,015
Ensembl chr12:17,042,932...17,043,015
G
Mir29a
microRNA 29a
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22048643
NCBI chr 4:59,650,608...59,650,695
G
Mir30d
microRNA 30d
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22048643
NCBI chr 7:100,136,391...100,136,472
Ensembl chr 7:100,136,391...100,136,472
G
Mir320a
microRNA 320a
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22048643
NCBI chr15:45,516,392...45,516,473
Ensembl chr15:45,516,392...45,516,473
G
Mir34b
microRNA 34b
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21339737
NCBI chr 8:51,410,244...51,410,327
Ensembl chr 8:51,410,244...51,410,327
G
Mir34c
microRNA 34c
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:24362009
NCBI chr 8:51,409,726...51,409,802
Ensembl chr 8:51,409,726...51,409,802
G
Mir374b
microRNA 374b
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22048643
NCBI chr X:68,591,732...68,591,799
Ensembl chr X:68,591,732...68,591,799
G
Mir877
microRNA 877
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22048643
NCBI chr20:2,811,476...2,811,560
Ensembl chr20:2,811,476...2,811,560
G
Mir92b
microRNA 92b
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22048643
NCBI chr 2:174,633,890...174,633,972
Ensembl chr 2:174,633,890...174,633,972
G
Mir99b
microRNA 99b
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22048643
NCBI chr 1:58,677,015...58,677,084
Ensembl chr 1:58,677,011...58,677,090
G
Mirlet7c1
microRNA let-7c-1
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:24704393
NCBI chr11:16,201,163...16,201,256
Ensembl chr11:16,201,158...16,201,265
G
Mitf
melanocyte inducing transcription factor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25401301
NCBI chr 4:130,409,020...130,621,145
Ensembl chr 4:130,409,217...130,621,145
G
Mmp14
matrix metallopeptidase 14
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23804419
NCBI chr15:27,887,795...27,897,020
Ensembl chr15:27,887,727...27,899,864
G
Mmp9
matrix metallopeptidase 9
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:14700523 PMID:19617202 PMID:22011395 PMID:30090327
NCBI chr 3:153,684,158...153,692,118
Ensembl chr 3:153,683,858...153,692,120
G
Muc1
mucin 1, cell surface associated
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:22457794
NCBI chr 2:174,635,989...174,640,738
Ensembl chr 2:174,635,995...174,640,733
G
Myc
MYC proto-oncogene, bHLH transcription factor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:2543982 PMID:12115494 PMID:29626521 PMID:31504995
NCBI chr 7:93,593,705...93,598,633
Ensembl chr 7:93,593,705...93,598,630
G
Mycn
MYCN proto-oncogene, bHLH transcription factor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22286764
NCBI chr 6:35,717,764...35,723,590
Ensembl chr 6:35,717,764...35,723,590
G
Myd88
MYD88, innate immune signal transduction adaptor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:24362818
NCBI chr 8:119,074,439...119,078,508
Ensembl chr 8:119,074,437...119,079,415
G
Nanog
Nanog homeobox
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:29626521
NCBI chr 4:155,943,737...155,951,116
Ensembl chr 4:155,943,737...155,951,116
G
Ncf1
neutrophil cytosolic factor 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21742780
NCBI chr12:22,485,382...22,494,647
Ensembl chr12:22,485,451...22,494,646
G
Nfe2l2
NFE2 like bZIP transcription factor 2
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:35124418
NCBI chr 3:60,594,239...60,621,712
Ensembl chr 3:60,594,242...60,621,737
G
Nfkb1
nuclear factor kappa B subunit 1
ISO
CTD Direct Evidence: marker/mechanism|therapeutic
CTD
PMID:20516118 PMID:28823542
NCBI chr 2:224,016,214...224,132,135
Ensembl chr 2:224,016,214...224,110,404
G
Nos2
nitric oxide synthase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:14700523
NCBI chr10:63,815,308...63,851,208
Ensembl chr10:63,815,308...63,851,210
G
Notch1
notch receptor 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22011395
NCBI chr 3:9,277,955...9,323,531
Ensembl chr 3:9,278,086...9,323,531
G
Nrg1
neuregulin 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19617202
NCBI chr16:59,250,658...60,304,519
Ensembl chr16:59,250,854...60,296,884
G
Nsd2
nuclear receptor binding SET domain protein 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:24076604
NCBI chr14:76,833,179...76,911,304
Ensembl chr14:76,835,637...76,913,641
G
Nt5e
5' nucleotidase, ecto
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:34773529
NCBI chr 8:89,271,046...89,314,918
Ensembl chr 8:89,270,696...89,314,881
G
Ocln
occludin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:24014025
NCBI chr 2:31,657,217...31,707,466
Ensembl chr 2:31,657,220...31,764,150
G
Parg
poly (ADP-ribose) glycohydrolase
ISO
CTD Direct Evidence: marker/mechanism|therapeutic
CTD
PMID:25628927 PMID:27003318
NCBI chr16:7,436,429...7,544,276
Ensembl chr16:7,436,476...7,544,273
G
Parp1
poly (ADP-ribose) polymerase 1
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:33771647
NCBI chr13:92,307,593...92,339,406
Ensembl chr13:92,307,586...92,339,404
G
Pdcd4
programmed cell death 4
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:27323401 PMID:27344173 PMID:28881718
NCBI chr 1:252,921,342...252,944,278
Ensembl chr 1:252,921,392...252,944,275
G
Pgbd5
piggyBac transposable element derived 5
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28504702
NCBI chr19:52,336,751...52,401,906
Ensembl chr19:52,336,751...52,402,397
G
Phgdh
phosphoglycerate dehydrogenase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21804546
NCBI chr 2:185,906,962...185,936,054
Ensembl chr 2:185,906,966...185,935,944
G
Phlpp1
PH domain and leucine rich repeat protein phosphatase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21750348
NCBI chr13:22,308,532...22,530,978
Ensembl chr13:22,308,548...22,530,977
G
Pim1
Pim-1 proto-oncogene, serine/threonine kinase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23565217
NCBI chr20:7,554,921...7,559,174
Ensembl chr20:7,554,921...7,559,174
G
Por
cytochrome p450 oxidoreductase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:15089088
NCBI chr12:20,951,058...20,999,198
Ensembl chr12:20,951,058...20,999,245
G
Prom1
prominin 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:29626521
NCBI chr14:66,989,545...67,094,534
Ensembl chr14:66,990,160...67,094,527
G
Pten
phosphatase and tensin homolog
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28823542
NCBI chr 1:230,630,443...230,697,070
Ensembl chr 1:230,630,338...230,696,838
G
Ptk2
protein tyrosine kinase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23804419
NCBI chr 7:105,126,725...105,331,848
Ensembl chr 7:105,126,728...105,331,783
G
Pxn
paxillin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28100775
NCBI chr12:41,060,791...41,107,952
Ensembl chr12:41,060,791...41,107,931
G
Rac1
Rac family small GTPase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22011395
NCBI chr12:11,037,028...11,057,251
Ensembl chr12:11,036,698...11,057,251
G
Rela
RELA proto-oncogene, NF-kB subunit
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23069812 PMID:29501572
NCBI chr 1:202,925,001...202,935,484
Ensembl chr 1:202,924,945...202,935,484
G
Satb2
SATB homeobox 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:26780400
NCBI chr 9:58,348,027...58,534,256
Ensembl chr 9:58,350,246...58,530,707
G
Slc16a1
solute carrier family 16 member 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:11953883
NCBI chr 2:192,123,755...192,144,617
Ensembl chr 2:192,124,289...192,144,611
G
Slc2a1
solute carrier family 2 member 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:11953883
NCBI chr 5:132,717,196...132,745,416
Ensembl chr 5:132,717,196...132,745,416
G
Slc40a1
solute carrier family 40 member 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21785164
NCBI chr 9:48,033,526...48,053,876
Ensembl chr 9:48,033,526...48,051,481
G
Snai1
snail family transcriptional repressor 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:24014025
NCBI chr 3:156,248,479...156,252,969
Ensembl chr 3:156,248,485...156,252,969
G
Sod1
superoxide dismutase 1
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:2982513 PMID:21742780
NCBI chr11:29,456,673...29,462,249
Ensembl chr11:29,456,558...29,462,249
G
Sod2
superoxide dismutase 2
ISO
CTD Direct Evidence: marker/mechanism|therapeutic
CTD
PMID:9067545 PMID:20516118 PMID:21742780 PMID:23964924 PMID:25448439
NCBI chr 1:47,638,318...47,645,163
Ensembl chr 1:47,636,528...47,645,189
G
Sp1
Sp1 transcription factor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22009531
NCBI chr 7:133,541,302...133,571,961
Ensembl chr 7:133,541,491...133,571,961
G
Stat3
signal transducer and activator of transcription 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25970160 PMID:26101800 PMID:34953898
NCBI chr10:85,811,206...85,863,057
Ensembl chr10:85,811,218...85,863,057
G
Suv39h1
SUV39H1 histone lysine methyltransferase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:29391238
NCBI chr X:14,421,028...14,433,993
Ensembl chr X:14,421,109...14,433,982
G
Suv39h1-ps1
SUV39H1 histone lysine methyltransferase, pseudogene 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:29391238
NCBI chr X:141,792,589...141,795,257
G
Tfrc
transferrin receptor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21785164
NCBI chr11:68,163,413...68,185,257
Ensembl chr11:68,163,413...68,185,257
G
Tgfb1
transforming growth factor, beta 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20172950
NCBI chr 1:81,196,532...81,212,848
Ensembl chr 1:81,196,532...81,212,847
G
Tlx1
T-cell leukemia, homeobox 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20972433
NCBI chr 1:244,005,057...244,011,318
Ensembl chr 1:244,005,057...244,011,318
G
Tnfaip3
TNF alpha induced protein 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:24362818
NCBI chr 1:13,709,211...13,724,291
Ensembl chr 1:13,709,206...13,725,282
G
Tp53
tumor protein p53
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:15550242 PMID:22009531
NCBI chr10:54,300,070...54,311,525
Ensembl chr10:54,300,048...54,311,524
G
Tp63
tumor protein p63
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22011395
NCBI chr11:74,838,858...75,049,764
Ensembl chr11:74,838,859...75,049,398
G
Tsc22d1
TSC22 domain family, member 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:15089088
NCBI chr15:51,750,489...51,850,958
Ensembl chr15:51,749,510...51,850,958
G
Vegfa
vascular endothelial growth factor A
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:30090327
NCBI chr 9:14,955,300...14,970,641
Ensembl chr 9:14,955,300...14,970,641
G
Vim
vimentin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:24014025
NCBI chr17:76,668,701...76,677,186
Ensembl chr17:76,668,647...76,677,187
G
Wnt5a
Wnt family member 5A
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19061910
NCBI chr16:3,697,032...3,718,230
Ensembl chr16:3,697,032...3,718,234
G
Zeb1
zinc finger E-box binding homeobox 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21954225
NCBI chr17:51,948,948...52,116,018
Ensembl chr17:51,948,948...52,115,214
G
Zeb2
zinc finger E-box binding homeobox 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21954225
NCBI chr 3:29,214,581...29,344,890
Ensembl chr 3:29,218,301...29,345,157
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all